February 2022 FDA Recall Drug by Lannett Company, Inc.
D-0558-2022 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Lannett Company, Inc. on February 9, 2022 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0558-2022

Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification results for related substances.
Initiated
02-09-2022
Reported
02-23-2022
Quantity
23,598 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lannett Company, Inc.
Product was distributed nationwide in the USA.
Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1768-36.

Batch or Lot Expiration Information

Lot# : 2664A, 2664B, Exp. date 07/2022; 2874A, 2874B, Exp. date 01/2023